Affordable Access

deepdyve-link
Publisher Website

The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.

Authors
  • Khoury, Hanane1
  • Lavoie, Louis1
  • Welner, Sharon1
  • Folkerts, Kerstin2
  • 1 LASER Analytica, Montreal, QC, Canada. , (Canada)
  • 2 Bayer Pharma AG, Wuppertal, Germany. , (Germany)
Type
Published Article
Journal
Cardiovascular therapeutics
Publication Date
April 2016
Volume
34
Issue
2
Pages
115–124
Identifiers
DOI: 10.1111/1755-5922.12169
PMID: 26670723
Source
Medline
Keywords
License
Unknown

Abstract

Despite gaps in the literature, this assessment showed that MACE's risk is substantial among patients with CAD or PAD and that the use of preventive therapies is suboptimal. Development of additional preventive therapies for these patients is warranted.

Report this publication

Statistics

Seen <100 times